chr16-29833950-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_005115.5(MVP):c.461G>A(p.Arg154Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000461 in 1,614,078 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005115.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MVP | NM_005115.5 | c.461G>A | p.Arg154Gln | missense_variant | 5/15 | ENST00000357402.10 | NP_005106.2 | |
MVP | NM_017458.3 | c.461G>A | p.Arg154Gln | missense_variant | 5/15 | NP_059447.2 | ||
MVP | NM_001293204.1 | c.461G>A | p.Arg154Gln | missense_variant | 4/14 | NP_001280133.1 | ||
MVP | NM_001293205.1 | c.461G>A | p.Arg154Gln | missense_variant | 4/13 | NP_001280134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MVP | ENST00000357402.10 | c.461G>A | p.Arg154Gln | missense_variant | 5/15 | 1 | NM_005115.5 | ENSP00000349977.5 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152132Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000509 AC: 128AN: 251464Hom.: 0 AF XY: 0.000625 AC XY: 85AN XY: 135904
GnomAD4 exome AF: 0.000466 AC: 681AN: 1461828Hom.: 1 Cov.: 31 AF XY: 0.000472 AC XY: 343AN XY: 727220
GnomAD4 genome AF: 0.000414 AC: 63AN: 152250Hom.: 0 Cov.: 30 AF XY: 0.000309 AC XY: 23AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at